2022
Machine learning models for prediction of adverse events after percutaneous coronary intervention
Niimi N, Shiraishi Y, Sawano M, Ikemura N, Inohara T, Ueda I, Fukuda K, Kohsaka S. Machine learning models for prediction of adverse events after percutaneous coronary intervention. Scientific Reports 2022, 12: 6262. PMID: 35428765, PMCID: PMC9012739, DOI: 10.1038/s41598-022-10346-1.Peer-Reviewed Original ResearchConceptsPercutaneous coronary interventionAdverse eventsRisk scoreHospital mortalityCoronary interventionConsecutive coronary artery disease patientsCoronary artery disease patientsAdverse periprocedural eventsLow-risk patientsMajor adverse eventsGood discriminationMulticenter registryPeriprocedural eventsDisease patientsClinical decisionLogistic regressionSpecific interventionsRisk predictionOverall risk predictionPatientsScoresInterventionMortalityAdequate discriminationOutcomes
2020
Applicability and Eligibility of the International Study of Comparative Health Effectiveness with Medical and Invasive Approaches (ISCHEMIA) for Patients who Underwent Revascularization with Percutaneous Coronary Intervention
Niimi N, Sawano M, Ikemura N, Nagai T, Nakano S, Shoji S, Shiraishi Y, Ueda I, Numasawa Y, Suzuki M, Noma S, Fukuda K, Kohsaka S. Applicability and Eligibility of the International Study of Comparative Health Effectiveness with Medical and Invasive Approaches (ISCHEMIA) for Patients who Underwent Revascularization with Percutaneous Coronary Intervention. Journal Of Clinical Medicine 2020, 9: 2889. PMID: 32906673, PMCID: PMC7564619, DOI: 10.3390/jcm9092889.Peer-Reviewed Original ResearchPercutaneous coronary interventionNon-eligible patientsComparative Health EffectivenessSevere ischemiaEligible patientsBaseline characteristicsCoronary interventionRCT patientsStable ischemic heart disease patientsHealth effectivenessMajor adverse cardiac eventsIschemic heart disease patientsRole of revascularizationAdverse cardiac eventsEarly invasive strategyInvasive Approaches (ISCHEMIA) trialHeart disease patientsInternational studiesSIHD patientsMulticenter registryPCI patientsCardiac eventsISCHEMIA trialDisease patientsBaseline cohort